A Prospective Hospital Based Observational Study On Electrolyte Changes Following Phototherapy In Neonatal Hyperbilirubinemia
Keywords:
Neonatal hyperbilirubinemia, phototherapy, hypocalcemia, hyponatremia, electrolyte imbalance, neonateAbstract
Background: Neonatal hyperbilirubinemia (NH) is a common condition affecting a large proportion of term and preterm infants. Phototherapy is a widely used treatment modality; however, it may result in electrolyte disturbances such as hypocalcemia, hyponatremia, and hyperkalemia, which pose significant clinical concerns.
Objectives: This study aimed to evaluate changes in serum calcium, sodium, and potassium levels in neonates undergoing phototherapy for unconjugated hyperbilirubinemia.
Methods: A hospital-based prospective observational study was conducted at RL Jalappa Hospital, Kolar, from August 2023 to August 2024. A total of 193 neonates aged between 24 hours to 14 days receiving phototherapy were enrolled. Electrolyte levels were measured before and after phototherapy and analyzed using appropriate statistical methods.
Results: Hypocalcemia was observed in 24% of neonates post-phototherapy, significantly more common in preterm and low birth weight infants (p<0.001). Hyponatremia was found in 3.5% of cases, with a higher prevalence in preterm and LBW neonates. Hyperkalemia occurred in 4.2% of neonates post-phototherapy, although no significant hypokalemia was detected. The duration of phototherapy and gestational age showed a statistically significant correlation with electrolyte disturbances.
Conclusion: Phototherapy in neonates is associated with significant electrolyte imbalances, particularly hypocalcemia and hyponatremia, especially in preterm and low birth weight infants. Routine monitoring of electrolytes during phototherapy is recommended to prevent complications.
Downloads
Metrics
References
Gale R, Seidman DS, Stevenson DK. Hyperbilirubinemia and early discharge. J Perinatol. 2001;21(1):40–3.
Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med (Lond). 2017 Dec 2;78(12):699–704.
Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12128–32.
Moncrieff MW, Dunn J. Phototherapy for hyperbilirubinaemia in very low birthweight infants. Arch Dis Child. 1976 Feb;51(2):124–6.
Bhutani VK, Wong R. Bilirubin-induced neurologic dysfunction (BIND). Semin Fetal Neonatal Med. 2015 Feb;20(1):1.
Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004 Jul;114(1):e130-53.
Yadav RK, Sethi RS, Sethi AS, Kumar L, Chaurasia S. The Evaluation of Effect of Phototherapy on Serum Calcium Level. Vol. 5, People’s Journal of Scientific Research. 2012.
Alizadeh-Taheri P, Sajjadian N, Eivazzadeh B. Prevalence of phototherapy induced hypocalcemia in term neonate. Iran J Pediatr. 2013 Dec;23(6):710–1.
Arora S, Narang G, Singh G. Serum Calcium Levels in Preterm and Term Neonates on Phototherapy. Journal of Nepal Paediatric Society. 2014 Mar 24;34(1):24–8.
Reddy AT, Vani Bai K, Shankar SU. Electrolyte Changes Following Phototherapy in Neonatal Hyperbilirubinemia [Internet]. Vol. 4, International Journal of Science and Research. 2013. Available from: www.ijsr.net
Karamifar H, Pishva N, Amirhakimi G. Prevalence of Phototherapy-Induced Hypocalcemia. Iran J Med Sci. 2002 Dec;27(4):166–
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
